| Year |
Citation |
Score |
| 2016 |
Wu W, Newcomb WW, Cheng N, Aksyuk A, Winkler DC, Steven AC. Internal Proteins of the Procapsid and Mature Capsids of Herpes Simplex Virus Type 1 Mapped by Bubblegram Imaging. Journal of Virology. PMID 26984725 DOI: 10.1128/Jvi.03224-15 |
0.469 |
|
| 2015 |
Aksyuk AA, Newcomb WW, Cheng N, Winkler DC, Fontana J, Heymann JB, Steven AC. Subassemblies and Asymmetry in Assembly of Herpes Simplex Virus Procapsid. Mbio. 6. PMID 26443463 DOI: 10.1128/Mbio.01525-15 |
0.538 |
|
| 2014 |
McHugh CA, Fontana J, Nemecek D, Cheng N, Aksyuk AA, Heymann JB, Winkler DC, Lam AS, Wall JS, Steven AC, Hoiczyk E. A virus capsid-like nanocompartment that stores iron and protects bacteria from oxidative stress. The Embo Journal. 33: 1896-911. PMID 25024436 DOI: 10.15252/Embj.201488566 |
0.362 |
|
| 2014 |
Yap ML, Klose T, Plevka P, Aksyuk A, Zhang X, Arisaka F, Rossmann MG. Structure of the 3.3MDa, in vitro assembled, hubless bacteriophage T4 baseplate. Journal of Structural Biology. 187: 95-102. PMID 24998893 DOI: 10.1016/J.Jsb.2014.06.008 |
0.602 |
|
| 2014 |
Fontana J, Nemecek D, McHugh CA, Aksyuk AA, Cheng N, Winkler DC, Bernard Heymann J, Hoiczyk E, Steven AC. Phage capsid-like structure of Myxococcus xanthus encapsulin, a protein shell that stores iron Microscopy and Microanalysis. 20: 1244-1245. DOI: 10.1017/S1431927614007958 |
0.401 |
|
| 2013 |
Fokine A, Zhang Z, Kanamaru S, Bowman VD, Aksyuk AA, Arisaka F, Rao VB, Rossmann MG. The molecular architecture of the bacteriophage T4 neck. Journal of Molecular Biology. 425: 1731-44. PMID 23434847 DOI: 10.1016/J.Jmb.2013.02.012 |
0.628 |
|
| 2012 |
Aksyuk AA, Bowman VD, Kaufmann B, Fields C, Klose T, Holdaway HA, Fischetti VA, Rossmann MG. Structural investigations of a Podoviridae streptococcus phage C1, implications for the mechanism of viral entry. Proceedings of the National Academy of Sciences of the United States of America. 109: 14001-6. PMID 22891295 DOI: 10.1073/Pnas.1207730109 |
0.632 |
|
| 2012 |
Aksyuk AA, Leiman PG, Kurochkina LP, Shneider MM, Kostyuchenko VA, Mesyanzhinov VV, Rossmann MG. Erratum: The tail sheath structure of bacteriophage T4: A molecular machine for infecting bacteria (EMBO Journal (2009) 28 (821-829) DOI: 10.1038/emboj.2009.36) The Embo Journal. 31. DOI: 10.1038/Emboj.2012.223 |
0.646 |
|
| 2011 |
Aksyuk AA, Kurochkina LP, Fokine A, Forouhar F, Mesyanzhinov VV, Tong L, Rossmann MG. Structural conservation of the myoviridae phage tail sheath protein fold. Structure (London, England : 1993). 19: 1885-94. PMID 22153511 DOI: 10.1016/J.Str.2011.09.012 |
0.688 |
|
| 2011 |
Aksyuk AA, Rossmann MG. Bacteriophage assembly. Viruses. 3: 172-203. PMID 21994726 DOI: 10.3390/v3030172 |
0.483 |
|
| 2010 |
Leiman PG, Arisaka F, van Raaij MJ, Kostyuchenko VA, Aksyuk AA, Kanamaru S, Rossmann MG. Morphogenesis of the T4 tail and tail fibers. Virology Journal. 7: 355. PMID 21129200 DOI: 10.1186/1743-422X-7-355 |
0.685 |
|
| 2010 |
Kaufmann B, Vogt MR, Goudsmit J, Holdaway HA, Aksyuk AA, Chipman PR, Kuhn RJ, Diamond MS, Rossmann MG. Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354. Proceedings of the National Academy of Sciences of the United States of America. 107: 18950-5. PMID 20956322 DOI: 10.1073/Pnas.1011036107 |
0.523 |
|
| 2009 |
Kurochkina LP, Aksyuk AA, Sachkova MY, Sykilinda NN, Mesyanzhinov VV. Characterization of tail sheath protein of giant bacteriophage phiKZ Pseudomonas aeruginosa. Virology. 395: 312-7. PMID 19822340 DOI: 10.1016/J.Virol.2009.09.015 |
0.554 |
|
| 2009 |
Aksyuk AA, Leiman PG, Shneider MM, Mesyanzhinov VV, Rossmann MG. The structure of gene product 6 of bacteriophage T4, the hinge-pin of the baseplate. Structure (London, England : 1993). 17: 800-8. PMID 19523898 DOI: 10.1016/J.Str.2009.04.005 |
0.679 |
|
| 2009 |
Aksyuk AA, Leiman PG, Kurochkina LP, Shneider MM, Kostyuchenko VA, Mesyanzhinov VV, Rossmann MG. The tail sheath structure of bacteriophage T4: a molecular machine for infecting bacteria. The Embo Journal. 28: 821-9. PMID 19229296 DOI: 10.1038/Emboj.2009.36 |
0.703 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2015 |
Winkler DC, Newcomb WW, Aksyuk A, Wu W, Cheng N, Steven AC. HSV-1 Scaffolding Protein Bubbles Readily in the Absence or Presence of DNA, Allowing its Localization in Immature and Mature Nucleocapsids Microscopy and Microanalysis. 21: 723-724. DOI: 10.1017/S1431927615004419 |
0.297 |
|
| 2022 |
Loo YM, McTamney PM, Arends RH, Abram ME, Aksyuk AA, Diallo S, Flores DJ, Kelly EJ, Ren K, Roque R, Rosenthal K, Streicher K, Tuffy KM, Bond NJ, Cornwell O, et al. The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in non-human primates and has an extended half-life in humans. Science Translational Medicine. eabl8124. PMID 35076282 DOI: 10.1126/scitranslmed.abl8124 |
0.207 |
|
| 2023 |
Roe TL, Brady T, Schuko N, Nguyen A, Beloor J, Guest JD, Aksyuk AA, Tuffy KM, Zhang T, Streicher K, Kelly EJ, Kijak GH. Molecular Characterization of AZD7442 (Tixagevimab-Cilgavimab) Neutralization of SARS-CoV-2 Omicron Subvariants. Microbiology Spectrum. e0033323. PMID 36877050 DOI: 10.1128/spectrum.00333-23 |
0.206 |
|
| 2023 |
Tuffy KM, Ahani B, Aksyuk AA, Avila M, Brady T, Kijak GH, Koh G, Levin MJ, Roe TL, Schuko N, Thissen J, Ustianowski A, Zhang T, Kelly EJ, Streicher K. Breakthrough SARS-CoV-2 Infections in the PROVENT Prevention Trial Were Not Associated with AZD7442 (Tixagevimab/Cilgavimab) Resistant Variants. The Journal of Infectious Diseases. PMID 37280116 DOI: 10.1093/infdis/jiad210 |
0.201 |
|
| 2023 |
Wilkins D, Langedijk AC, Lebbink RJ, Morehouse C, Abram ME, Ahani B, Aksyuk AA, Baraldi E, Brady T, Chen AT, Chi H, Choi EH, Cohen R, Danilenko DM, Gopalakrishnan V, et al. Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data. The Lancet. Infectious Diseases. PMID 36940703 DOI: 10.1016/S1473-3099(23)00062-2 |
0.179 |
|
| 2023 |
Maaske J, Sproule S, Falsey AR, Sobieszczyk ME, Luetkemeyer AF, Paulsen GC, Riddler SA, Robb ML, Rolle CP, Sha BE, Tong T, Ahani B, Aksyuk AA, Bansal H, Egan T, et al. Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated. Frontiers in Immunology. 13: 1062067. PMID 36713413 DOI: 10.3389/fimmu.2022.1062067 |
0.166 |
|
| 2023 |
Ahani B, Tuffy KM, Aksyuk AA, Wilkins D, Abram ME, Dagan R, Domachowske JB, Guest JD, Ji H, Kushnir A, Leach A, Madhi SA, Mankad VS, Simões EAF, Sparklin B, et al. Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials. Nature Communications. 14: 4347. PMID 37468530 DOI: 10.1038/s41467-023-40057-8 |
0.159 |
|
| 2024 |
Wilkins D, Yuan Y, Chang Y, Aksyuk AA, Núñez BS, Wählby-Hamrén U, Zhang T, Abram ME, Leach A, Villafana T, Esser MT. Author Correction: Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants. Nature Medicine. PMID 38649782 DOI: 10.1038/s41591-024-03006-6 |
0.11 |
|
| 2022 |
Aksyuk AA, Bansal H, Wilkins D, Stanley AM, Sproule S, Maaske J, Sanikommui S, Hartman WR, Sobieszczyk ME, Falsey AR, Kelly EJ. AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection. Cell Reports. Medicine. 100882. PMID 36610390 DOI: 10.1016/j.xcrm.2022.100882 |
0.105 |
|
| 2022 |
Wilkins D, Aksyuk AA, Ruzin A, Tuffy KM, Green T, Greway R, Fikes B, Bonhomme CJ, Esser MT, Kelly EJ. Validation and performance of a multiplex serology assay to quantify antibody responses following SARS-CoV-2 infection or vaccination. Clinical & Translational Immunology. 11: e1385. PMID 35495877 DOI: 10.1002/cti2.1385 |
0.102 |
|
| 2023 |
Wilkins D, Yuan Y, Chang Y, Aksyuk AA, Núñez BS, Wählby-Hamrén U, Zhang T, Abram ME, Leach A, Villafana T, Esser MT. Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants. Nature Medicine. PMID 37095249 DOI: 10.1038/s41591-023-02316-5 |
0.1 |
|
| 2024 |
Ahani B, Tuffy KM, Aksyuk AA, Wilkins D, Abram ME, Dagan R, Domachowske JB, Guest JD, Ji H, Kushnir A, Leach A, Madhi SA, Mankad VS, Simões EAF, Sparklin B, et al. Author Correction: Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials. Nature Communications. 15: 3026. PMID 38589384 DOI: 10.1038/s41467-024-47421-2 |
0.094 |
|
| 2023 |
Forte-Soto P, Albayaty M, Brooks D, Arends RH, Tillinghast J, Aksyuk AA, Bouquet J, Chen C, Gebre A, Kubiak RJ, Pilla Reddy V, Seegobin S, Streicher K, Templeton A, Esser MT. Safety, Tolerability and Pharmacokinetics of Half-Life Extended SARS-CoV-2 Neutralizing Monoclonal Antibodies AZD7442 (Tixagevimab/Cilgavimab) in Healthy Adults. The Journal of Infectious Diseases. PMID 36683419 DOI: 10.1093/infdis/jiad014 |
0.056 |
|
| 2020 |
Layman H, Rickert KW, Wilson S, Aksyuk AA, Dunty JM, Natrakul D, Swaminathan N, DelNagro CJ. Development and validation of a multiplex immunoassay for the simultaneous quantification of type-specific IgG antibodies to E6/E7 oncoproteins of HPV16 and HPV18. Plos One. 15: e0229672. PMID 32214362 DOI: 10.1371/journal.pone.0229672 |
0.045 |
|
| 1998 |
Zaraisky G, Aksyuk A, Seltmann R, Shatov V, Fedkin A. Phosphorus in granites associated with W-Mo, W-Sn, and Ta-Nb mineralization Acta Universitatis Carolinae, Geologica. 42: 194-199. |
0.019 |
|
| 2023 |
Cole J, Cąpała-Szczurko I, Roseti S, Chen C, Caveney S, Aksyuk AA, Streicher K, Ponnarambil S, Colice G. Effect of Tezepelumab on the Humoral Immune Response to Seasonal Quadrivalent Influenza Vaccination in Patients with Moderate to Severe Asthma: The Phase 3b VECTOR Study. Pulmonary Therapy. PMID 38064153 DOI: 10.1007/s41030-023-00245-9 |
0.016 |
|
| Hide low-probability matches. |